240 related articles for article (PubMed ID: 22178321)
21. Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.
Petosa C; Morand P; Baudin F; Moulin M; Artero JB; Müller CW
Mol Cell; 2006 Feb; 21(4):565-72. PubMed ID: 16483937
[TBL] [Abstract][Full Text] [Related]
22. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
23. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids activate Epstein Barr virus lytic replication through the upregulation of immediate early BZLF1 gene expression.
Yang EV; Webster Marketon JI; Chen M; Lo KW; Kim SJ; Glaser R
Brain Behav Immun; 2010 Oct; 24(7):1089-96. PubMed ID: 20466055
[TBL] [Abstract][Full Text] [Related]
25. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
[TBL] [Abstract][Full Text] [Related]
26. Role of histone modification on transcriptional regulation and HIV-1 gene expression: possible mechanisms of periodontal diseases in AIDS progression.
Imai K; Ochiai K
J Oral Sci; 2011 Mar; 53(1):1-13. PubMed ID: 21467809
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors Is Essential for Optimal Lytic Viral Replication.
Li Y; Long X; Huang L; Yang M; Yuan Y; Wang Y; Delecluse HJ; Kuang E
J Virol; 2016 Jan; 90(2):887-903. PubMed ID: 26537683
[TBL] [Abstract][Full Text] [Related]
28. Histone acetylation and reactivation of Epstein-Barr virus from latency.
Jenkins PJ; Binné UK; Farrell PJ
J Virol; 2000 Jan; 74(2):710-20. PubMed ID: 10623733
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.
Murata T; Kondo Y; Sugimoto A; Kawashima D; Saito S; Isomura H; Kanda T; Tsurumi T
J Virol; 2012 May; 86(9):4752-61. PubMed ID: 22357272
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase.
Murata T; Hotta N; Toyama S; Nakayama S; Chiba S; Isomura H; Ohshima T; Kanda T; Tsurumi T
J Biol Chem; 2010 Jul; 285(31):23925-35. PubMed ID: 20516063
[TBL] [Abstract][Full Text] [Related]
31. The role of DNA hypomethylation, histone acetylation and in vivo protein-DNA binding in Epstein-Barr virus-induced CD23 upregulation.
Szenthe K; Koroknai A; Banati F; Bathori Z; Niller HH; Wolf H; Nagy N; Klein E; Minarovits J; Salamon D
Biochem Biophys Res Commun; 2013 May; 435(1):8-15. PubMed ID: 23583387
[TBL] [Abstract][Full Text] [Related]
32. A role for the nucleosome assembly proteins TAF-Iβ and NAP1 in the activation of BZLF1 expression and Epstein-Barr virus reactivation.
Mansouri S; Wang S; Frappier L
PLoS One; 2013; 8(5):e63802. PubMed ID: 23691099
[TBL] [Abstract][Full Text] [Related]
33. BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.
Long X; Li Y; Yang M; Huang L; Gong W; Kuang E
J Virol; 2016 Sep; 90(17):7880-93. PubMed ID: 27334596
[TBL] [Abstract][Full Text] [Related]
34. Retrograde Regulation by the Viral Protein Kinase Epigenetically Sustains the Epstein-Barr Virus Latency-to-Lytic Switch To Augment Virus Production.
Li X; Kozlov SV; El-Guindy A; Bhaduri-McIntosh S
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189703
[TBL] [Abstract][Full Text] [Related]
35. MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling.
Gruffat H; Manet E; Sergeant A
EMBO Rep; 2002 Feb; 3(2):141-6. PubMed ID: 11818339
[TBL] [Abstract][Full Text] [Related]
36. Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency.
Bryant H; Farrell PJ
J Virol; 2002 Oct; 76(20):10290-8. PubMed ID: 12239305
[TBL] [Abstract][Full Text] [Related]
37. Microbial interaction of periodontopathic bacterium Porphyromonas gingivalis and HIV-possible causal link of periodontal diseases to AIDS progression-.
Imai K; Victoriano AF; Ochiai K; Okamoto T
Curr HIV Res; 2012 Apr; 10(3):238-44. PubMed ID: 22384843
[TBL] [Abstract][Full Text] [Related]
38. Regulation of Epstein-Barr virus reactivation from latency.
Murata T
Microbiol Immunol; 2014 Jun; 58(6):307-17. PubMed ID: 24786491
[TBL] [Abstract][Full Text] [Related]
39. Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.
Giunco S; Celeghin A; Gianesin K; Dolcetti R; Indraccolo S; De Rossi A
Cell Death Dis; 2015 May; 6(5):e1774. PubMed ID: 26018735
[TBL] [Abstract][Full Text] [Related]
40. Relationship between Porphyromonas gingivalis, Epstein-Barr virus infection and reactivation in periodontitis.
Sugano N; Ikeda K; Oshikawa M; Idesawa M; Tanaka H; Sato S; Ito K
J Oral Sci; 2004 Dec; 46(4):203-6. PubMed ID: 15901063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]